Company intelligence / Profile preview

Salvea

Los Angeles, California, United States6sense.com ↗

Ownership: Private
Development stage: Other

Overview

Salve Therapeutics is developing an AI/ML-powered cloud bioengineering platform called VirCAD to enable rapid design of new viral vectors for drug delivery. The company also develops digital health applications such as WarfaRef for warfarin self-monitoring and DecidED for medical decision support. No clinical results or marketed products have been reported as of June 2025.

Therapeutic areas: HematologyOther
Modalities: Gene therapyViral vector-based therapyDigital health applicationSoftware/bioinformatics toolDevice/software integrationDecision-support software
Industry: Drug Discovery Services

Partnerships

Not publicly disclosed as of June 2025

Beyond the preview

Go deeper on Salvea.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salvea.

Explore the full profile